Browsing by Author Graham, Garry G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2010Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrationsDavies, Michael; Hawkins, Clare; Pattison, David; Fu, Shanlin; Graham, Garry G.; Kajer, Tracey; Keh, Jeremy S.; Kettle, Anthony J.; Koelsch, Maud; Mallak, Roger; Milligan, Marian K.; Newsham, Dawn W.; Nguyen, Ly Q.; Rees, Martin D; Scott, Kieran F; Ziegler, John B.; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstituteAcetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations, Biochemical Pharmacology, vol.79, 8, 2010,pp 1156-1164
2007Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolMcLachlan, Andrew; Stocker, Sophie; Day, Richard O; Graham, Garry G.; Hicks, Mark; Williams, Kenneth M.; Pharmacy; PharmacyClinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol, Clinical Pharmacokinetics, vol.46,(8),2007,pp 623-644
2012Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?Stocker, Sophie; Anderson, Jacqueline; Day, Richard; Graham, Garry G.; Lee, Ming Han; Nolan, D; Phillips, Elizabeth; Sullivan, John; Williams, Kenneth M.; PharmacyInitiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?, Internal Medicine Journal, vol.42, 4, 2012,pp 411-416
2010Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteersStocker, Sophie; Day, Richard O; Graham, Garry G.; Ng, Daniel; Williams, Kenneth M.; PharmacyLack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers, European Journal of Clinical Pharmacology, vol.Online, N/A,pp 1-5
2013The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findingsDavies, Michael; Day, Richard O; Graham, Garry G.; Mohamudally, Anthoulla; Scott, Kieran; Central Clinical School: Heart Research InstituteThe modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings, Inflammopharmacology, vol.21, 3, 2013,pp 201-232
2006Oncogenic action of phospholipase A(2) in prostate cancer.Dong, Qihan; Patel, Manish; Sved, P; Graham, Garry G.; Russell, Pamela J.; Scott, Kieran F.; Central Clinical School: Medicine; Western Clinical School: Surgery; Central Clinical School: MedicineOncogenic action of phospholipase A(2) in prostate cancer., Cancer Letters, vol.240,(1),2006,pp 9-16
2004Oncogenic Action Of Secreted Phospholipase A2 In Prostate Cancer.Boulas, John; Dong, Qihan; King, Nicholas; Nikolov, Blagoy; Singh, Jaskirat; Sved, P; Tsatralis, Tania; Gelb, Michael H.; Graham, Garry G.; McLeod, Duncan; Nallan, Laxman; Russell, Pamela J.; Sajinovic, Mila; Scott, Kieran F.; Medicine; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Medicine; Central Clinical School: Office; Central Clinical School: Medicine; MedicineOncogenic Action Of Secreted Phospholipase A2 In Prostate Cancer., Cancer Research, vol.64,(19),2004,pp 6934-6940
2008Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacyStocker, Sophie; Chung, Yewon; Day, Richard O; Graham, Garry G.; PharmacyOptimizing therapy with allopurinol: Factors limiting hypouricemic efficacy, American Journal of the Medical Sciences, vol.335, 3, 2008,pp 219-226
2008Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjectsMcLachlan, Andrew; Stocker, Sophie; Day, Richard O; Graham, Garry G.; Williams, Kenneth M.; Pharmacy; PharmacyPharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects, Clinical Pharmacokinetics, vol.47, 2, 2008,pp 111-118
2011Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with GoutMcLachlan, Andrew; Stocker, Sophie; Day, Richard O; Graham, Garry G.; Williams, K.M.; Pharmacy; PharmacyPharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout, Journal of Rheumatology, vol.38, 5, 2011,pp 904-910
2012The pharmacokinetics of oxypurinol in people with goutMcLachlan, Andrew; Stocker, Sophie; Day, Richard O; Graham, Garry G.; Kirkpatrick, Carl M. J.; Savic, Radojka; Williams, Kenneth M.; Pharmacy; PharmacyThe pharmacokinetics of oxypurinol in people with gout, British Journal of Clinical Pharmacology, vol.74, 3, 2012,pp 477-489